Aliskiren (a direct renin inhibitor) is typically prevented with ARBs in people with diabetic issues as a result of higher risk of kidney challenges and higher potassium. Clinicians also evaluation other blood-force brokers, especially if You will find a historical past of symptomatic hypotension.